{"id":"https://openalex.org/W2076701129","doi":"https://doi.org/10.1016/s0924-9338(14)78121-0","title":"EPA-0775 \u2013 Efficacy of lisdexamfetamine dimesylate and atomoxetine in child and adolescent subgroups from a head-tohead, double-blind, randomized trial in patients with attention-deficit/hyperactivity disorder","display_name":"EPA-0775 \u2013 Efficacy of lisdexamfetamine dimesylate and atomoxetine in child and adolescent subgroups from a head-tohead, double-blind, randomized trial in patients with attention-deficit/hyperactivity disorder","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2076701129","doi":"https://doi.org/10.1016/s0924-9338(14)78121-0","mag":"2076701129"},"language":"en","primary_location":{"id":"doi:10.1016/s0924-9338(14)78121-0","doi":"https://doi.org/10.1016/s0924-9338(14)78121-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-9338(14)78121-0","pdf_url":null,"source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066919809","display_name":"Regina Dittmann","orcid":"https://orcid.org/0000-0003-1886-1864","observed_orcids":["https://orcid.org/0000-0003-1886-1864"]},"institutions":[{"id":"https://openalex.org/I4210105615","display_name":"Central Institute of Mental Health","ror":"https://ror.org/01hynnt93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210105615"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R.W. Dittmann","raw_affiliation_strings":["Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany","institution_ids":["https://openalex.org/I4210105615"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113481113","display_name":"E Card\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087626","display_name":"Hospital Son Llatzer","ror":"https://ror.org/003ez4w63","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210087626"]},{"id":"https://openalex.org/I50441567","display_name":"Universitat de les Illes Balears","ror":"https://ror.org/03e10x626","country_code":"ES","type":"education","lineage":["https://openalex.org/I50441567"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Cardo","raw_affiliation_strings":["Son Ll\u00e0tzer Hospital and Research Institute on Health Sciences, University of the Balearic Islands, Palma de Mallorca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Son Ll\u00e0tzer Hospital and Research Institute on Health Sciences, University of the Balearic Islands, Palma de Mallorca, Spain","institution_ids":["https://openalex.org/I4210087626","https://openalex.org/I50441567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076676344","display_name":"David Coghill","orcid":"https://orcid.org/0000-0003-3017-9737","observed_orcids":["https://orcid.org/0000-0003-3017-9737"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D.R. Coghill","raw_affiliation_strings":["Division of Neuroscience, University of Dundee, Dundee, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neuroscience, University of Dundee, Dundee, United Kingdom","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024672699","display_name":"P\u00e9ter Nagy","orcid":"https://orcid.org/0000-0002-0256-3304","observed_orcids":["https://orcid.org/0000-0002-0256-3304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Nagy","raw_affiliation_strings":["Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic, Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic, Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic, Budapest, Hungary","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109483193","display_name":"Colleen S. Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.S. Anderson","raw_affiliation_strings":["Global Clinical Programs, Shire Development LLC, Wayne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Programs, Shire Development LLC, Wayne, United Kingdom","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064064053","display_name":"Ben A. Adeyi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Adeyi","raw_affiliation_strings":["Global Biostatistics, Shire Development LLC, Wayne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Biostatistics, Shire Development LLC, Wayne, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"B. Caballero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155387","display_name":"Shire (Switzerland)","ror":"https://ror.org/01zz06256","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210086742","https://openalex.org/I4387155387","https://openalex.org/I44892455"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"B. Caballero","raw_affiliation_strings":["Clinical Development and Medical Affairs, Shire AG, Eysins, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Shire AG, Eysins, Switzerland","institution_ids":["https://openalex.org/I4387155387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113725864","display_name":"P. Hodgkins","orcid":"https://orcid.org/0009-0007-4268-9511","observed_orcids":["https://orcid.org/0009-0007-4268-9511"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Hodgkins","raw_affiliation_strings":["Global Health Economics and Outcomes Research, Shire Development LLC, Wayne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics and Outcomes Research, Shire Development LLC, Wayne, United Kingdom","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109098321","display_name":"Richard H. Civil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Civil","raw_affiliation_strings":["Clinical Development and Medical Affairs, Shire Development LLC, Wayne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Shire Development LLC, Wayne, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":null,"first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisdexamfetamine-dimesylate","display_name":"lisdexamfetamine dimesylate","score":0.9350000023841858},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":1.0},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9980000257492065},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.5360000133514404},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":1.0},{"id":"https://openalex.org/keywords/adhd-rs-iv","display_name":"ADHD-RS-IV","score":0.7919999957084656},{"id":"https://openalex.org/keywords/clinical-global-impression-improvement","display_name":"CGI-I","score":0.6970000267028809},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7089999914169312},{"id":"https://openalex.org/keywords/stimulant-medication","display_name":"stimulant medication","score":0.414000004529953},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.4020000100135803},{"id":"https://openalex.org/keywords/age-differences-in-treatment-response","display_name":"age differences in treatment response","score":0.5529999732971191},{"id":"https://openalex.org/keywords/safety-profile","display_name":"safety profile","score":0.39100000262260437},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.49799999594688416},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.38199999928474426},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.9431725740432739},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.7358174324035645},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.62987220287323},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6109892129898071},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.548296332359314},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.4871377646923065},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4749845862388611},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4238743782043457},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41330161690711975},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38997799158096313},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3426159918308258}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0924-9338(14)78121-0","doi":"https://doi.org/10.1016/s0924-9338(14)78121-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-9338(14)78121-0","pdf_url":null,"source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2066516000","https://openalex.org/W2067898213","https://openalex.org/W7098114966","https://openalex.org/W7095254113","https://openalex.org/W2086997214","https://openalex.org/W2098734885","https://openalex.org/W2987638586","https://openalex.org/W215407455","https://openalex.org/W1996061461","https://openalex.org/W2050019679"],"abstract_inverted_index":{"Symptoms":[0],"of":[1,18,26,56],"attention-deficit/hyperactivity":[2],"disorder":[3],"(ADHD)":[4],"appear":[5],"in":[6,24,143,193,202],"childhood":[7],"and":[8,13,22,28,42,70,96,127,196,204],"may":[9],"persist":[10],"into":[11],"adolescence":[12],"beyond.":[14],"Evaluate":[15],"the":[16],"efficacy":[17,132],"lisdexamfetamine":[19],"dimesylate":[20],"(LDX)":[21],"atomoxetine":[23],"subgroups":[25],"children":[27,89,203],"adolescents":[29,98],"with":[30,40,138,166],"ADHD.":[31],"In":[32],"this":[33],"9-week,":[34],"double-blind":[35],"study,":[36],"patients":[37],"aged":[38,90,99],"6\u201317":[39],"ADHD":[41,63],"an":[43],"inadequate":[44],"response":[45],"to":[46,53],"previous":[47,139],"methylphenidate":[48],"therapy":[49],"were":[50,136,200],"randomized":[51],"(1:1)":[52],"optimized":[54,106],"doses":[55,107],"LDX":[57],"or":[58],"atomoxetine.":[59],"Efficacy":[60],"measures":[61],"included":[62],"Rating":[64],"Scale":[65],"IV":[66],"(ADHD-RS-IV)":[67],"total":[68,121,145],"score":[69,76,122,146,169],"dichotomized":[71],"Clinical":[72],"Global":[73],"Impressions-Improvement":[74],"(CGI-I)":[75],"(improved,":[77],"1\u20132;":[78],"not":[79],"improved,":[80],"3\u20137).":[81],"The":[82],"full":[83],"analysis":[84],"set":[85],"(n=262)":[86],"comprised":[87],"194":[88],"6\u201312":[91],"(LDX,":[92,101],"n=93;":[93],"atomoxetine,":[94,103,114],"n=101)":[95],"68":[97],"13\u201317":[100],"n=34;":[102],"n=34).":[104],"Mean":[105],"were:":[108],"LDX,":[109],"52.5":[110],"(SD,":[111],"16.10)":[112],"mg/day;":[113],"40.2":[115],"(20.05)":[116],"mg/day.":[117],"Baseline":[118],"mean":[119],"ADHD-RS-IV":[120,144],"was":[123],"similar":[124],"across":[125],"treatment":[126,190],"age":[128],"groups.":[129],"Table":[130],"shows":[131],"results;":[133],"safety":[134],"profiles":[135],"consistent":[137],"studies.Empty":[140],"CellLDXAtomoxetineMean":[141],"change":[142],"by":[147,170,208],"visit":[148,171],"9":[149,172],"(95%":[150,173],"confidence":[151,174],"interval)Overall\u221226.3":[152],"(\u221228.4,":[153],"\u221224.2)\u221219.4":[154],"(\u221221.6,":[155],"\u221217.2)Children\u221227.5":[156],"(\u221229.8,":[157],"\u221225.1)\u221219.4":[158],"(\u221222.0,":[159],"\u221216.7)Adolescents\u221222.9":[160],"(\u221227.3,":[161],"\u221218.5)\u221219.5":[162],"(\u221223.7,":[163],"\u221215.3)Patients":[164],"(%)":[165],"improved":[167],"CGI-I":[168],"interval)Overall81.7":[175],"(75.0,":[176],"88.5)63.6":[177],"(55.4,":[178],"71.8)Children83.9":[179],"(76.4,":[180],"91.3)61.2":[181],"(51.6,":[182],"70.9)Adolescents75.8":[183],"(61.1,":[184],"90.4)70.6":[185],"(55.3,":[186],"85.9)":[187],"Within":[188],"each":[189],"group,":[191],"improvements":[192],"symptomatological":[194],"scales":[195],"global":[197],"improvement":[198],"ratings":[199],"observed":[201],"adolescents.":[205],"Study":[206],"funded":[207],"Shire.":[209]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}